Clinical outcomes after delayed thyroid surgery in patients with papillary thyroid microcarcinoma
Authors:
- 1 July 2017
- journal article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 177 (1) , 25-31
Abstract
Objective: Active surveillance is an option for patients with papillary thyroid microcarcinoma (PTMC). However, the long-term clinical outcomes after delayed surgery remain unclear. We compared the long-term clinical outcomes of PTMC patients according to the time interval between initial diagnosis and surgery. Design and methods: In this individual risk factor-matched cohort study, PTMC patients were classified into three groups according to the delay period: ≤6 months, 6–12 months and >12 months. Patients were matched by age, sex, extent of surgery, initial tumor size as measured by ultrasonography (US), and by the presence of extrathyroidal extension, multifocal tumors and central cervical lymph node metastasis. We compared the dynamic risk stratification (DRS) and the development of structural persistent/recurrent disease of patients. Results: A total of 2863 patients were assigned to three groups. Their mean age was 50 years, 81% were female and 66% underwent lobectomy. The mean tumor size at the initial US was 0.63 cm. There were no significant differences in clinicopathological characteristics between groups after individual risk factor matching. Comparison of the DRS revealed no significant difference according to the delay period (P = 0.07). During the median 4.8 years of follow-up, there were no significant differences in the development of structural recurrent/persistent disease (P = 0.34) and disease-free survival (P = 0.25) between groups. Conclusions: In PTMC patients, delayed surgery was not associated with higher risk of structural recurrent/persistent disease compared to immediate surgery. These findings support the notion that surgical treatment can be safely delayed in patients with PTMC under close monitoring.Keywords
This publication has 16 references indexed in Scilit:
- Active Surveillance for Papillary Thyroid Microcarcinoma: New Challenges and Opportunities for The Health Care SystemEndocrine Practice, 2016
- The Revised 2016 Korean Thyroid Association Guidelines for Thyroid Nodules and Cancers: Differences from the 2015 American Thyroid Association GuidelinesEndocrinology and Metabolism, 2016
- Features Predictive of Distant Metastasis in Papillary Thyroid MicrocarcinomasThyroid®, 2016
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate SurgeryThyroid®, 2016
- A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary MicrocarcinomaThyroid®, 2016
- Recent Changes in the Clinical Outcome of Papillary Thyroid Carcinoma With Cervical Lymph Node MetastasisThe Journal of Clinical Endocrinology & Metabolism, 2015
- Differences in the Recurrence and Mortality Outcomes Rates of Incidental and Nonincidental Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-Analysis of 21 329 Person-Years of Follow-upThe Journal of Clinical Endocrinology & Metabolism, 2014
- Nodal metastasis and recurrence in papillary thyroid microcarcinomaEndocrine, 2014
- Patient Age Is Significantly Related to the Progression of Papillary Microcarcinoma of the Thyroid Under ObservationThyroid®, 2014